miR-155 as a novel clinical target for hematological malignancies.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 2, doi. 10.1093/carcin/bgz183
- By:
- Publication type:
- Article
Works matching IS 01433334 AND DT 2020 AND VI 41 AND IP 1
Results: 8
1
2
Genetic variants in m<sup>6</sup>A modification genes are associated with colorectal cancer risk.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 8, doi. 10.1093/carcin/bgz165
- By:
- Publication type:
- Article
3
Editorial.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 1, doi. 10.1093/carcin/bgaa006
- By:
- Publication type:
- Article
4
Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 44, doi. 10.1093/carcin/bgz086
- By:
- Publication type:
- Article
5
ROS control in human iPS cells reveals early events in spontaneous carcinogenesis.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 36, doi. 10.1093/carcin/bgz081
- By:
- Publication type:
- Article
6
TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting β-catenin.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 25, doi. 10.1093/carcin/bgz079
- By:
- Publication type:
- Article
7
Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 18, doi. 10.1093/carcin/bgz160
- By:
- Publication type:
- Article
8
The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 1, p. 56, doi. 10.1093/carcin/bgz085
- By:
- Publication type:
- Article